Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

IVACONICA 4.6 MG/24 H TRANSDERMAL PATCH

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Package leaflet: Information for the user
Ivaconica 4.6 mg/24 h transdermal patch
Ivaconica 9.5 mg/24 h transdermal patch
rivastigmine
Read all of this leaflet carefully before you start using this medicine because it contains
important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet.
What is in this leaflet:
1.
What Ivaconica is and what it is used for
2.
What you need to know before you use Ivaconica
3.
How to use Ivaconica
4.
Possible side effects
5.
How to store Ivaconica
6.
Contents of the pack and other information

1. What Ivaconica is and what it is used for
The active substance of Ivaconica is rivastigmine.
Rivastigmine belongs to a class of substances called cholinesterase inhibitors. In patients with Alzheimer’s
dementia, certain nerve cells die in the brain, resulting in low levels of the neurotransmitter
acetylcholine (a substance that allows nerve cells to communicate with each other). Rivastigmine
works by blocking the enzymes that break down acetylcholine: acetylcholinesterase and
butyrylcholinesterase. By blocking these enzymes, rivastigmine allows levels of acetylcholine to be
increased in the brain, helping to reduce the symptoms of Alzheimer’s disease.
Ivaconica is used for the treatment of adult patients with mild to moderately severe Alzheimer’s
dementia, a progressive brain disorder that gradually affects memory, intellectual ability and
behaviour.

2. What you need to know before you use Ivaconica
Do not use Ivaconica
if you are allergic to rivastigmine (the active substance in Ivaconica) or any of the
other ingredients of this medicine (listed in section 6).
if you have ever had an allergic reaction to a similar type of medicine (carbamate derivatives).
- if you have a skin reaction spreading beyond the patch size, if there is a more intense local
reaction (such as blisters, increasing skin inflammation, swelling) and if it does not improve
within 48 hours after removal of the transdermal patch.
If this applies to you, tell your doctor and do not apply Ivaconica transdermal patches.
Warnings and precautions
Talk to your doctor or pharmacist before using Ivaconica
if you have, or have ever had, an irregular heartbeat.
if you have, or have ever had, an active stomach ulcer.
if you have, or have ever had, difficulties in passing urine.
if you have, or have ever had, seizures.
1

-

if you have, or have ever had, asthma or a severe respiratory disease.
if you suffer from trembling.
if you have a low body weight.
if you have gastrointestinal reactions such as feeling sick (nausea), being sick (vomiting) and
diarrhoea. You may become dehydrated (losing too much fluid) if vomiting or diarrhoea are
prolonged.
if you have impaired liver function.
If any of these apply to you, your doctor may need to monitor you more closely while you are on this
medicine.
If you have not applied a patch for several days, do not apply the next one before you have talked to
your doctor.
Use in children and adolescents
There is no relevant use of Ivaconica in the paediatric population in the treatment of Alzheimer’s
disease.
Other medicines and Ivaconica
Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines.
Ivaconica might interfere with anticholinergic medicines some of which are medicines used to relieve
stomach cramps or spasms (e.g. dicyclomine), to treat Parkinson’s disease (e.g. amantadine) or to
prevent motion sickness (e.g. diphenhydramine, scopolamine, or meclizine).
If you have to undergo surgery whilst using Ivaconica transdermal patches, tell your doctor that you
are using them because they may exaggerate the effects of some muscle relaxants during anaesthesia.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask
your doctor or pharmacist for advice before taking this medicine.
If you are pregnant, the benefits of using Ivaconica must be assessed against the possible effects on
your unborn child. Ivaconica should not be used during pregnancy unless clearly necessary.
You should not breast-feed during treatment with Ivaconica transdermal patches.
Driving and using machines
Your doctor will tell you whether your illness allows you to drive vehicles and use machines safely.
Ivaconica transdermal patches may cause fainting or severe confusion. If you feel faint or confused
do not drive, use machines or perform any other tasks that require your attention.

3. How to use Ivaconica
Always use this medicine exactly as described in this leaflet and as your doctor has told you. Check
with your doctor or pharmacist if you are not sure.
IMPORTANT:
• Take off the previous patch before putting ONE new patch on.
• Only wear one Ivaconica patch per day.
• Do not cut the patch into pieces.
• Press the patch firmly in place for at least 30 seconds using the palm of the hand.
How to start treatment
Your doctor will tell you which Ivaconica transdermal patch is most suitable for you.
• Treatment usually starts with Ivaconica 4.6 mg/24 h.
2



The recommended usual daily dose is Ivaconica 9.5 mg/24 h. If well tolerated, the treating
physician may consider increasing the dose to 13.3 mg/24 h. (The 13.3 mg/24 h dose strength
cannot be achieved with this product. For conditions where this strength should be used, please
refer to other rivastigmine products for which transdermal patches of the 13.3 mg/24 h strength
are available.

• Only wear one transdermal patch at a time and replace the patch with a new one after 24 hours.
During the course of the treatment your doctor may adjust the dose to suit your individual needs.
If you have not applied a patch for three days, do not apply the next one before you have talked to your
doctor. Transdermal patch treatment can be resumed at the same dose if treatment is not interrupted for
more than three days. Otherwise your doctor will restart your treatment on Ivaconica 4.6 mg/24 h.
Ivaconica can be used with food, drink and alcohol.
Where to apply Ivaconica transdermal patches
• Before you apply a patch, make sure that your skin is clean, dry and hairless, free of any powder,
oil, moisturiser, or lotion that could keep the patch from sticking to your skin properly, free of cuts,
rashes and/or irritations.
• Carefully remove any existing patch before putting on a new one. Having multiple patches on
your body could expose you to an excessive amount of this medicine which could be potentially
dangerous.
• Apply ONE patch per day to ONLY ONE of the following locations shown in the following
diagram:
- left upper arm or right upper arm
- left upper chest or right upper chest (avoid breast)
- left upper back or right upper back
- left lower back or right lower back

the

Every 24 hours take off the previous patch before
putting ONE new patch on to ONLY ONE of
following possible locations.

When changing the patch, you must remove the previous day’s patch before you apply the new one
to a different location of skin each time (for example on the right side of your body one day, then on
the left side the next day, and on your upper body one day, then on your lower body the next day).
Do not apply a new patch to that same location of skin twice within 14 days.
How to apply Ivaconica transdermal patches
Ivaconica patches are thin, tan coloured, plastic patches that stick to the skin. Each patch is sealed in a
sachet that protects it until you are ready to put it on. Do not open the sachet or remove a patch until
just before you apply it.

3

Carefully remove the existing patch before putting on a new one.
For patients starting treatment for the first time and for patients
restarting rivastigmine after treatment interruption, please begin
with the second picture.

Each patch is sealed in its own protective sachet. You should only
open the sachet when you are ready to apply the patch.
Cut the sachet at both scissors marks, but not further than the
indicated line. Tear the sachet to open. Do not cut the entire length
of the sachet in order to avoid damaging of the patch.
Remove the patch from the sachet.
Remove the cover sheet from the top, skin-coloured side of
the patch and discard it.

A protective liner covers the sticky side of the patch.
Peel off one side of the protective liner and do not touch the sticky
part of the patch with the fingers.

Put the sticky side of the patch on the upper or lower back or
upper arm or chest and then peel off the second side of the protective
liner.

Then press the patch firmly in place for at least 30 seconds using the
palm of the hand to make sure that the edges stick well.

If it helps you, you may write, for example, the day of the week, on the patch with a thin ball point
pen.
4

The patch should be worn continuously until it is time to replace it with a new one. You may wish to
experiment with different locations when applying a new patch, to find ones that are most
comfortable for you and where clothing will not rub on the patch.
How to remove Ivaconica transdermal patches
Gently pull at one edge of the patch to remove it slowly from the skin. In case the adhesive residue is
left over on your skin, gently soak the area with warm water and mild soap or use baby oil to remove
it. Alcohol or other dissolving liquids (nail polish remover or other solvents) should not be used.
You should wash your hands with soap and water after removing the patch. In case of contact with
eyes or if the eyes become red after handling the patch, rinse immediately with plenty of water and
seek medical advice if symptoms do not resolve.
Can you wear Ivaconica transdermal patches when you are bathing, swimming, or in the sun?
• Bathing, swimming or showering should not affect the patch. Make sure the patch does not
loosen during these activities.
• Do not expose the patch to any external heat sources (e.g. excessive sunlight, saunas, solarium)
for long periods of time.
What to do if a patch falls off?
If a patch falls off, apply a new one for the rest of the day, then replace it at the same time as usual the
next day.
When and for how long to apply Ivaconica transdermal patches?
• To benefit from treatment, you must apply a new patch every day, preferably at the same time of
day.
• Only wear one Ivaconica patch at a time and replace the patch with a new one after 24 hours.
If you use more Ivaconica than you should
If you accidentally apply more than one patch, remove all the patches from your skin, then inform
your doctor that you have accidentally applied more than one patch. You may require medical
attention. Some people who have accidentally taken too much rivastigmine have experienced feeling
sick (nausea), being sick (vomiting), diarrhoea, high blood pressure and hallucinations. Slow heart beat
and fainting may also occur.
If you forget to use Ivaconica
If you find you have forgotten to apply a patch, apply one immediately. You may apply the next patch
at the usual time the next day. Do not apply two patches to make up for the one that you missed.
If you stop using Ivaconica
Tell your doctor or pharmacist if you stop using the patch.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You may have side effects more often when you start your medicine or when your dose is increased.
Usually, the side effects will slowly go away as your body gets used to the medicine.
Take off your patch and tell your doctor straight away, if you notice any of the following side
effects which could become serious:
Common (may affect up to 1 in 10 people)
• loss of appetite
5





feeling dizzy
feeling agitated or sleepy
urinary incontinence (inability to retain adequate urine)

Uncommon (may affect up to 1 in 100 people):
• problems with your heartbeat such as slow heartbeat
• seeing things that are not really there (hallucination)
• stomac ulcer
• dehydration (losing too much fluid)
• hyperactivity (high level of activity, restlessness)
• aggression
Rare (may affect up to 1 in 1,000 people):
• falling
Very rare (may affect up to 1 in 10,000 people):
• stiff arms or legs
• trembling hands
Not known (frequency cannot be estimated from the available data)

allergic reaction where the patch was used, such as blisters or inflamed skin

the signs of Parkinson’s disease get worse – such as tremor, stiffness and shuffling

inflammation of the pancreas – signs include serious upper stomach pain, often with feeling
sick (nausea) or being sick (vomiting)

fast or uneven heartbeat

high blood pressure

fits (seizures)

liver disorders (yellow skin, yellowing of the whites of the eyes, abnormal darkening of the
urine or unexplained nausea, vomiting, tiredness and loss of appetite)

changes in tests which show how well the liver is working

feeling restless
Take off your patch and tell your doctor straight away, if you notice any of the side effects above.
Other side effects seen with rivastigmine capsules or oral solution and which may occur with the
patch:
Common (may affect up to 1 in 10 people):
• too much saliva
• loss of appetite
• feeling restless
• generally feeling unwell
• trembling or feeling confused
• increased sweating
Uncommon (may affect up to 1 in 100 people):
• uneven heart rate (e.g. fast heart rate)
• difficulty sleeping
• accidental falls
Rare (may affect up to 1 in 1,000 people):
• fits (seizures)
• ulcer in the intestine
• chest pain - this may be caused by heart spasm
Very rare (may affect up to 1 in 10, 000 people):
• high blood pressure
6






inflammation of the pancreas – the signs include serious upper stomach pain, often with feeling
sick (nausea) or being sick (vomiting)
bleeding in the gut – shows as blood in stools or when being sick
seeing things that are not there (hallucinations)
some people who have been violently sick have had tearing of the tube that connects your mouth
with your stomach (oesophagus)

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet.

5.







How to store Ivaconica
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date, which is stated on the carton and sachet after EXP.
The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Keep the transdermal patch in the sachet until use.
Do not use any patch that is damaged or shows signs of tampering.
After removing a patch, fold it in half with the sticky sides on the inside and press them together.
Return the used patch to its sachet and dispose of it in such a way that children cannot handle it.
Do not touch your eyes with your fingers and wash your hands with soap and water after
removing the patch. If your community burns domestic rubbish, you can dispose of the patch with
your domestic rubbish. Otherwise, return used patches to a pharmacy, preferably in the original
packaging.

6. Contents of the pack and other information
What Ivaconica contains
The active substance is rivastigmine.
Ivaconica 4.6 mg/24 h transdermal patches: Each patch releases 4.6 mg of
rivastigmine per 24 hours is 4.6 cm2 and contains 6.9 mg of rivastigmine.
- Ivaconica 9.5 mg/24 h transdermal patches: Each patch releases 9.5 mg of
rivastigmine per 24 hours is 9.2 cm2 and contains 13.8 mg of rivastigmine.
- The other ingredients are:
Matrix:
- poly [(2-ethylhexyl)acrylate,vinylacetate]
- medium- and high molecular weight polyisobutene
- silica, colloidal anhydrous
- paraffin, light liquid
Backing liner:
- polyethylene/thermoplastic resin/aluminium coated polyester film
Release liner:
- polyester film, fluoropolymer-coated
Orange printing ink
What Ivaconica looks like and contents of the pack
Each transdermal patch is a thin patch. The outer layer is tan coloured and printed with an orange
printing ink as following:
“RIV-TDS 4.6 mg/24 h”
“RIV-TDS 9.5 mg/24 h”
One transdermal patch is sealed in one sachet. The patches are available in packs containing 7 or 30
sachets and in multipacks containing 60 or 90 sachets. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Acino AG
7

Am Windfeld 35
83714 Miesbach
Germany

This medicinal product is authorised in the Member States of the EEA under the following
names:
for DE/H/3304:
Germany
Germany
Austria
Austria
Belgium
Belgium
Spain
Spain
France
France
Hungary
Hungary
Ireland
Ireland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Poland
Poland
Portugal
Portugal
Romania
Romania
Sweden
Sweden
Slovenia
Slovenia
Slovakia
Slovakia
United Kingdom
United Kingdom

Rivastigmin Acino 4,6 mg/24 Stunden transdermales Pflaster
Rivastigmin Acino 9,5 mg/24 Stunden transdermales Pflaster
Rivastigmin Acino 4.6 mg/24 h transdermales Pflaster
Rivastigmin Acino 9.5 mg/24 h transdermales Pflaster
Ivaconica 4,6 mg/24 h Pleisters voor transdermaal gebruik
Ivaconica 9,5 mg/24 h Pleisters voor transdermaal gebruik
Rivastigmin Acino 4.6 mg/24 h Parche transdérmico
Rivastigmin Acino 9.5 mg/24 h Parche transdérmico
Ivaconica 4.6 mg/24 h Dispositif transdermique
Ivaconica 9.5 mg/24 h Dispositif transdermique
Rivastigmin Acino 4.6 mg/24 h Transzdermális tapasz
Rivastigmin Acino 9.5 mg/24 h Transzdermális tapasz
Ivaconica 4.6 mg/24 h transdermal patch
Ivaconica 9.5 mg/24 h transdermal patch
Rivastigmina Acino
Rivastigmina Acino
Rivastigmin Acino 4.6 mg/24 h transdermales Pflaster
Rivastigmin Acino 9.5 mg/24 h transdermales Pflaster
Rivastigmin Acino 4.6 mg/24 h Pleister voor transdermaal gebruik
Rivastigmin Acino 9.5 mg/24 h Pleister voor transdermaal gebruik
Ivaconica
Ivaconica
Rivastigmin Acino
Rivastigmin Acino
Rivastigmina Acino 4.6 mg/24 h Plasture transdermic
Rivastigmina Acino 9.5 mg/24 h Plasture transdermic
Ivaconica 4.6 mg/24 h Depotplåster
Ivaconica 9.5 mg/24 h Depotplåster
Rivastigmin Acino 4,6 mg/24 h transdermalni obliži
Rivastigmin Acino 9,5 mg/24 h transdermalni obliži
Rivastigmin Acino 4.6 mg/24 h Transdermálna náplasť
Rivastigmin Acino 9.5 mg/24 h Transdermálna náplasť
Ivaconica 4.6 mg/24 h transdermal patch
Ivaconica 9.5 mg/24 h transdermal patch

8

for DE/H/3305:
Germany
Germany
Bulgaria
Bulgaria
Czec Republic
Czec Republic
Estonia
Estonia
Hungary
Hungary
Lithuania
Lithuania
Latvia
Latvia
Poland
Poland
Romania
Romania
Slovakia
Slovakia

Werendi 4,6 mg/24 Stunden transdermales Pflaster
Werendi 9,5 mg/24 Stunden transdermales Pflaster
Werendi 4.6 mg/24 h Трансдермален пластир
Werendi 9.5 mg/24 h Трансдермален пластир
Werendi 4.6 mg/24 h Transdermální náplast
Werendi 9.5 mg/24 h Transdermální náplast
Werendi
Werendi
Werendi 4.6 mg/24 h Transzdermális tapasz
Werendi 9.5 mg/24 h Transzdermális tapasz
Werendi 4.6 mg/24 h Transderminiai pleistrai
Werendi 9.5 mg/24 h Transderminiai pleistrai
Werendi 4,6 mg/24 stundās transdermāls plāksteris
Werendi 9,5 mg/24 stundās transdermāls plāksteris
Werendi
Werendi
Werendi 4.6 mg/24 h Plasture transdermic
Werendi 9.5 mg/24 h Plasture transdermic
Werendi 4.6 mg/24 h Transdermálna náplasť
Werendi 9.5 mg/24 h Transdermálna náplasť

for DE/H/3306:
Germany
Germany
Denmark
Denmark
Finland
Finland
Norway
Norway
Sweden
Sweden

Miestigacin 4,6 mg/24 Stunden transdermales Pflaster
Miestigacin 9,5 mg/24 Stunden transdermales Pflaster
Miestigacin 4.6 mg/24 h Depotplaster
Miestigacin 9.5 mg/24 h Depotplaster
Miestigacin 4.6 mg/24 h Depotlaastari
Miestigacin 9.5 mg/24 h Depotlaastari
Miestigacin 4.6 mg/24 h Depotplaster
Miestigacin 9.5 mg/24 h Depotplaster
Miestigacin 4.6 mg/24 h Depotplåster
Miestigacin 9.5 mg/24 h Depotplåster

for DE/H/3307:
Germany
Germany
Greece
Greece
Spain
Spain
France
France
Italy
Italy
United Kingdom
United Kingdom

Ivaconica 4,6 mg/24 Stunden transdermales Pflaster
Ivaconica 9,5 mg/24 Stunden transdermales Pflaster
Ivaconica 4,6 mg/24 h Διαδερμικό έμπλαστρο
Ivaconica 9,5 mg/24 h Διαδερμικό έμπλαστρο
Ivaconica 4.6 mg/24 h Parche transdérmico
Ivaconica 9.5 mg/24 h Parche transdérmico
Ivaconica 4.6 mg/24 h Dispositif transdermique
Ivaconica 9.5 mg/24 h Dispositif transdermique
Ivaconica
Ivaconica
Ivaconica 4.6 mg/24 h transdermal patch
Ivaconica 9.5 mg/24 h transdermal patch

9

for DE/H/3308:
Germany
Germany
Spain
Spain
France
France
Italy
Italy
Netherlands
Netherlands
Portugal
Portugal

Demelora 4,6 mg/24 Stunden transdermales Pflaster
Demelora 9,5 mg/24 Stunden transdermales Pflaster
Demelora 4.6 mg/24 h Parche transdérmico
Demelora 9.5 mg/24 h Parche transdérmico
Demelora 4.6 mg/24 h Dispositif transdermique
Demelora 9.5 mg/24 h Dispositif transdermique
Demelora
Demelora
Demelora 4.6 mg/24 h Pleister voor transdermaal gebruik
Demelora 9.5 mg/24 h Pleister voor transdermaal gebruik
Demelora
Demelora

for DE/H/3309+3311:
Germany
Germany

Rivastigmin Acino 4,6 mg/24 Stunden transdermales Pflaster
Rivastigmin Acino 9,5 mg/24 Stunden transdermales Pflaster

for DE/H/3310:
Germany
Germany

Rivastigmin beta 4,6 mg/24 Stunden transdermales Pflaster
Rivastigmin beta 9,5 mg/24 Stunden transdermales Pflaster

This leaflet was last revised in: 03/2013

10

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide